Prognosis based on subtype classification. (A): PFS in HER2‐enriched versus non‐HER2‐enriched subgroups. (B): PFS in luminal (including normal‐like) versus nonluminal subgroups.
Abbreviations: CI, confidence interval; HER2, human epidermal growth factor receptor 2; PFS, progression‐free survival.